Whether youre stopping Semaglutide (Ozempic, Wegovy), Tirzepatide (Mounjaro), or another GLP-1 medication due to side effects, cost, or personal choice, understanding how to discontinue safely can help you protect the progress youve worked so hard for
A realistic UK approval window is late 2027 to mid 2028, with NHS availability through NICE technology appraisal arriving in 2029 at the earliest
Meer over voeding die past bij een GLP-1 behandeling lees je in ons artikel over voeding bij GLP-1 gebruik
However, various clinical trials have shown promising results for Ozempic in reducing insulin resistance and, as a result, improving outcomes for the following associated conditions and diseases
Key timeline for Eli Lillys orforglipron: The approval of the first oral GLP-1 pill for weight loss expands the treatment landscape for obesity
M., Hunt, C